Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient has provided written informed consent
• Aged 18 years or older at written informed consent
• Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria
• Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter
• Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up
Locations
Other Locations
Australia
Peter MacCallum Cancer Centre
RECRUITING
Melbourne
Contact Information
Primary
Abby Douglas
Abby.Douglas@petermac.org
03 855 96136
Backup
Beatrice Sim
Beatrice.Sim@petermac.org
Time Frame
Start Date: 2023-12-01
Estimated Completion Date: 2027-04
Participants
Target number of participants: 10
Related Therapeutic Areas
Sponsors
Leads: Peter MacCallum Cancer Centre, Australia